Earnings Release • Oct 28, 2021
Earnings Release
Open in ViewerOpens in native device viewer

VÉLIZY-VILLACOUBLAY, France — October 28, 2021 — Dassault Systèmes (Euronext Paris: #14003TT8, DSY.PA) announces IFRS unaudited financial results for the third quarter ended September 30, 2021. The Group's Board of Directors approved these results on October 27, 2021. This press release also includes financial information on a non-IFRS basis and reconciliations with IFRS figures in the Appendix to this communication.
(unaudited, non-IFRS, in constant currencies)
"Virtual technology was born for sustainability: it was first used in industry for virtual prototyping, for doing things right the first time while saving materials and resources, capitalizing knowledge and knowhow, and improving environmental handprints. Sustainability is all about life cycle, about connecting the dots. Offering a multi-scale, multi-discipline and inclusive approach to sustainable innovation in Manufacturing Industries, Life Sciences & Healthcare and Infrastructure & Cities is possible thanks to the 3DEXPERIENCE industry solutions.
In light of the COP26 challenges, the 3DEXPERIENCE platform with science-based virtual twin experience are unparalleled catalysts to rationalize our eco-bill, and ultimately reinvent a more sustainable economy. 'IFWE experience the virtual twin, we can harmonize product, nature and life': this is the very core of Dassault Systèmes.
Earlier this month, our MEDIDATA NEXT conference drew a record number of participants. We shared significant technological advancements that will continue to position our clients at the vanguard of, among others, decentralized clinical trials, personalized therapies, and seamless connectivity between patients, site investigators and sponsors. Progressing from things to life is a core part of our strategy and mission. We believe we're entering an industry Renaissance in Life Sciences & Healthcare; together, we have a significant opportunity to positively impact patients and drive meaningful change for Healthcare."
| In millions of Euros, | IFRS | IFRS | ||||||
|---|---|---|---|---|---|---|---|---|
| except per share data and percentages |
Q3 2021 | Q3 2020 | Change | Change in constant currencies |
YTD 2021 | YTD 2020 | Change | Change in constant currencies |
| Total Revenue | 1,158.7 | 1,029.6 | 13% | 12% | 3,492.4 | 3,233.0 | 8% | 12% |
| Software Revenue | 1,044.6 | 934.3 | 12% | 11% | 3,163.1 | 2,907.3 | 9% | 12% |
| Operating Margin | 20.5% | 12.1% | +8.3pts | 20.1% | 12.0% | +8.1pts | ||
| Diluted EPS * | 0.14 | 0.07 | 94% | 0.41 | 0.22 | 85% | ||
| In millions of Euros, except per share data and percentages |
Non-IFRS | Non-IFRS | ||||||
| Q3 2021 | Q3 2020 | Change | Change in constant currencies |
YTD 2021 | YTD 2020 | Change | Change in constant currencies |
|
| Total Revenue | 1,158.8 | 1,030.2 | 12% | 12% | 3,493.9 | 3,245.2 | 8% | 11% |
* 2020 figures have been restated in order to reflect the five-for-one share split on Dassault Systèmes' share effected on July 7, 2021
Software Revenue 1,044.7 934.9 12% 11% 3,164.4 2,918.3 8% 12%
Diluted EPS * 0.22 0.16 40% 40% 0.67 0.51 31% 36%
Operating Margin 33.8% 28.2% +5.6pts 33.3% 28.1% +5.2pts
(unaudited, all revenue growth rates in constant currencies)
well as contract research organizations (CROs). Precision medicine, decentralized clinical trials and synthetic control arms remain important mid and long-term growth drivers.
Industries: We saw very positive dynamics with the vast majority of our end markets growing non-IFRS revenue double digits, including core manufacturing industries - Transportation & Mobility, Aerospace & Defense and Industrial Equipment. For Home & Lifestyle and Business Services, non-IFRS revenue grew more than 20%.
Key growth drivers: Non-IFRS 3DEXPERIENCE software revenue increased 14% to 30% of software revenue. The strong value proposition of the 3DEXPERIENCE platform drove a number of important, larger client wins during the period. Non-IFRS cloud software revenue grew 26%, representing 21.1% of non-IFRS software revenue. The cloud has been a preferred option for new market entrants as it affords the rapid deployment of enterprise level technologies.
Dassault Systèmes' Chief Operating Officer & Chief Financial Officer Commentary (revenue growth rates in constant currencies, data on a non-IFRS basis, cash flow IFRS)
"We're pleased with our third quarter results. Our team executed well, leveraging continued positive business momentum across geographies and industries. Total revenue grew 12%, with license revenue increasing 24%. This is reflecting double digit growth in our core industrial end markets and in Life Sciences & Healthcare. We also benefited from continued acceleration of 3DEXPERIENCE and cloud adoption.
Profitability remained high, reflecting strong revenue growth and a continuation of the pandemic-related expense and headcount tailwinds. Diluted EPS grew 40% in constant currencies, above guidance. Operating margin expanded 560 basis points to 33.8%. Finally, year-to-date cash flow from operations totaled €1.25 billion, contributing to achieve our deleveraging target.
As we look to the fourth quarter, we are increasing our non-IFRS diluted EPS objective range to €0.94 - €0.95 or 25%-27% growth from +19%-21% previously, capturing the incremental earnings upside from the third quarter and increased revenue visibility while expenses remain unchanged. We thank our clients for their continued trust that allow us to pursue our investments in people."
(Unaudited, all revenue growth rates reported in constant currencies)
equivalents and short-term investments of €2.67 billion and debt related to borrowings of €3.87 billion at September 30, 2021.
Dassault Systèmes' fourth quarter and full year 2021 financial objectives presented below are given on a non-IFRS basis and reflect the principal 2021 currency exchange rate assumptions for the US dollar and Japanese yen as well as the potential impact from additional non-Euro currencies:
| Q4 2021 | FY 2021 | |
|---|---|---|
| Total Revenue | €1.307 to €1.332 billion | €4.800 to €4.825 billion |
| Growth | +7-9% | +8% |
| Growth ex FX* | +7-9% | +10-11% |
| Software revenue growth * | +8-9% | +11% |
| Of which licenses and other software revenue growth * |
+8-12% | +21-22% |
| Of which recurring revenue growth * | +8-9% | +8-9% |
| Services revenue growth * | +4-9% | +4-6% |
| Operating Margin | 35.8% – 36.4% | 34.0% – 34.1% |
| EPS Diluted | €0.27 - €0.28 | €0.94 - €0.95 |
| Growth | +10-15% | +25%-27% |
| US dollar | \$1.20 per Euro | \$1.20 per Euro |
| Japanese yen (before hedging) | JPY 130.0 per Euro | JPY 129.9 per Euro |
* Growth in Constant Currencies
These objectives are prepared and communicated only on a non-IFRS basis and are subject to the cautionary statement set forth below.
The 2021 non-IFRS financial objectives set forth above do not take into account the following accounting elements below and are estimated based upon the 2021 principal currency exchange rates above: contract liabilities write-downs estimated at approximately €2 million; share-based compensation expenses, including related social charges, estimated at approximately €204 million; amortization of acquired intangibles and of tangibles reevaluation, estimated at approximately €365 million, largely impacted by the acquisition of Medidata; and lease incentives of acquired companies at approximately €3 million. The above objectives also do not include any impact from other operating income and expenses, net principally comprised of acquisition, integration and restructuring expenses, and impairment of goodwill and acquired intangible assets; from one-time items included in financial revenue; from one-time tax effects; and from the income tax effects of these non-IFRS adjustments. Finally, these estimates do not include any new stock option or share grants, or any new acquisitions or restructuring completed after September 30, 2021.
October 14, 2021: Dassault Systèmes enters into a strategic partnership with Bloom to leverage social inference analytics: Bloom is the first artificial intelligence platform dedicated to qualitative, predictive and strategic analysis of social networks. Through its strategic partnership, Dassault Systèmes will incorporate Bloom's unique and proprietary social inference technology, enabling clients to understand influence dynamics and anticipate major technological and sociological trends.
Today, Thursday, October 28, 2021, Dassault Systèmes will host a webcasted presentation at 9:00 AM London Time/ 10:00 AM Paris time and will then host a conference call at 9:00 AM New York time / 2:00 PM London time / 3:00 PM Paris time. The webcasted presentation and conference call will be available online by accessing investor.3ds.com.
Additional investor information is available at investor.3ds.com or by calling Dassault Systèmes' Investor Relations at +33.1.61.62.69.24.
Fourth Quarter 2021 Earnings Release: February 3, 2022
Statements herein that are not historical facts but express expectations or objectives for the future, including but not limited to statements regarding the Group's non-IFRS financial performance objectives are forward-looking statements. Such forward-looking statements are based on Dassault Systèmes management's current views and assumptions and involve known and unknown risks and uncertainties. Actual results or performances may differ materially from those in such statements due to a range of factors.
The Group's actual results or performance may be materially negatively affected by numerous risks and uncertainties, as described in the "Risk Factors" section 1.9 of the 2020 Universal Registration Document ('Document d'enregistrement universel') filed with the AMF (French Financial Markets Authority) on March 19, 2021, as updated in the 2021 Half-Year Financial Report ('Rapport Financier Semestriel' as of June 30, 2021) filed with the AMF on July 27, 2021, both available on the Group's website www.3ds.com.
In particular, please refer to the risk factor "Uncertain Global Economic Environment" in section 1.9.1.1 of the 2020 Universal Registration Document set out below for ease of reference:
"In light of the uncertainties regarding economic, business, social, health, climate and geopolitical conditions at the global level, Dassault Systèmes' revenue, net earnings and cash flows may grow more slowly, whether on an annual or quarterly basis, mainly due to the following factors:
Dassault Systèmes makes every effort to take into consideration this uncertain macroeconomic outlook. Dassault Systèmes' business results, however, may not develop as anticipated. Furthermore, due to factors affecting sales of Dassault Systèmes' products and services, there may be a substantial time lag between an improvement in global economic and business conditions and an upswing in the Group's business results.
The economic context (as notably caused by the COVID-19 pandemic crisis) may also adversely impact the financial situation or financing capabilities of Dassault Systèmes' existing and potential customers, commercial and technology partners, some of whom may be forced to temporarily close sites or cease operations due to cash flow and profitability issues. Dassault Systèmes' ability to collect outstanding receivables may be affected. In addition, the economic environment could generate increased price pressure, as customers seek lower prices from various competitors, which could negatively impact Dassault Systèmes' revenue, financial performance and market position.
In preparing such forward-looking statements, the Group has in particular assumed an average US dollar to euro exchange rate of US\$1.20 per €1.00 as well as an average Japanese yen to euro exchange rate of JPY130.0 to €1.00 before hedging for the fourth quarter and US\$1.20 per €1.00 as well as an average Japanese yen to euro exchange rate of JPY129.9 to €1.00 before hedging for the full year 2021. However, currency values fluctuate, and the Group's results may be significantly affected by changes in exchange rates.
Readers are cautioned that the supplemental non-IFRS financial information presented in this press release is subject to inherent limitations. It is not based on any comprehensive set of accounting rules or principles and should not be considered in isolation from or as a substitute for IFRS measurements. The supplemental non-IFRS financial information should be read only in conjunction with the Company's consolidated financial statements prepared in accordance with IFRS. Furthermore, the Group's supplemental non-IFRS financial information may not be comparable to similarly titled "non-IFRS" measures used by other companies. Specific limitations for individual non-IFRS measures are set forth in the Company's 2020 Universal Registration Document filed with the AMF on March 19, 2021.
In the tables accompanying this press release the Group sets forth its supplemental non-IFRS figures for revenue, operating income, operating margin, net income and diluted earnings per share, which exclude the effect of adjusting the carrying value of acquired companies' deferred revenue, share-based compensation expense and related social charges, the amortization of acquired intangible assets and of tangibles reevaluation, certain other operating income and expense, net, including impairment of goodwill and acquired intangibles, the effect of adjusting lease incentives of acquired companies, certain one-time items included in financial revenue and other, net, and the income tax effect of the non-IFRS adjustments and certain one-time tax effects. The tables also set forth the most comparable IFRS financial measure and reconciliations of this information with non-IFRS information.
Social media:
Connect with Dassault Systèmes on Twitter Facebook LinkedIn YouTube
Dassault Systèmes, the 3DEXPERIENCE Company, is a catalyst for human progress. We provide business and people with collaborative virtual environments to imagine sustainable innovations. By creating 'virtual twin experience' of the real world with our 3DEXPERIENCE platform and applications, our customers push the boundaries of innovation, learning and production.
Dassault Systèmes' 20,000 employees are bringing value to more than 290,000 customers of all sizes, in all industries, in more than 150 countries. For more information, visit www.3ds.com
©2021 Dassault Systèmes. All rights reserved. 3DEXPERIENCE, the Compass icon, the 3DS logo, CATIA, BIOVIA, GEOVIA, SOLIDWORKS, 3DVIA, ENOVIA, EXALEAD, NETVIBES, MEDIDATA, CENTRIC PLM, 3DEXCITE, SIMULIA, DELMIA, and IFWE are commercial trademarks or registered trademarks of Dassault Systèmes, a French "société européenne" (Versailles Commercial Register # B 322 306 440), or its subsidiaries in the United States and/or other countries. All other trademarks are owned by their respective owners. Use of any Dassault Systèmes or its subsidiaries trademarks is subject to their express written approval.
| Corporate | François-José Bordonado Béatrix Martinez Marie Dumas |
[email protected] | +33 (0) 1 61 62 69 24 |
|---|---|---|---|
| United States and Canada | Callie Gauzer | Callie. [email protected] | +1 (607) 240 3219 |
| FTI Consulting | Jamie Ricketts Arnaud de Cheffontaines |
+44 (0)203 727 1000 +33 (0)1 47 03 69 48 |
| Corporate / France | Arnaud MALHERBE | [email protected] | +33 (0)1 61 62 87 73 |
|---|---|---|---|
| North America | Suzanne MORAN | [email protected] | +1 (781) 810 3774 |
| EMEAR | Virginie BLINDENBERG | [email protected] | +33 (0) 1 61 62 84 21 |
| China | Grace MU | [email protected] | +86 10 6536 2288 |
| India | Santanu BHATTACHARYA | [email protected] | +91 9717972875 |
| Japan | Yukiko SATO | [email protected] | +81 3 4321 3841 |
| Korea | Jeemin JEONG | [email protected] | +82 2 3271 6653 |
| AP South | Pallavi MISRA | [email protected] | +65 9437 0714 |
(Due to rounding, numbers presented throughout this and other documents may not add up precisely to the totals provided and percentages may not precisely reflect the absolute figures).
Glossary of Definitions Non-IFRS Financial Information Acquisitions and Foreign Exchange Impact Condensed consolidated statements of income Condensed consolidated balance sheets Condensed consolidated cash flow statements IFRS – non-IFRS reconciliation
We have followed a long-standing policy of measuring our revenue performance and setting our revenue objectives exclusive of currency in order to measure in a transparent manner the underlying level of improvement in our total revenue and software revenue by activity, industry, geography and product line. We believe it is helpful to evaluate our growth exclusive of currency impacts, particularly to help understand revenue trends in our business. Therefore, we provide percentage increases or decreases in our revenue, expenses and EPS (in both IFRS as well as non-IFRS) to eliminate the effect of changes in currency values, particularly the U.S. dollar and the Japanese yen, relative to the euro. Variations in constant currencies are obtained by comparing the performances of the current period with those of the comparable period recalculated using the average exchange rates of the current period.
While constant currency calculations are not considered to be an IFRS measure, we do believe these measures are critical to understanding our global revenue results and to compare with many of our competitors who report their financial results in U.S. dollars. Therefore, we are including this calculation for comparing IFRS revenue figures for comparable periods as well as for comparing non-IFRS revenue figures for comparable periods. All constant currency information is provided on an approximate basis.
In addition to financial indicators on the entire Group's scope, Dassault Systèmes provides growth excluding the impact of acquisitions, also named organic growth. The related growth rate is determined by restating the scope of activity as follows: for entities entering the consolidation scope in the current year, subtracting the contribution of the acquisition from the aggregates of the current year and, for entities entering the consolidation scope in the previous year, subtracting the contribution of the acquisition from January 1st of the current year, until the last day of the month of the current year when the acquisition was made the previous year.
Dassault Systèmes' Industries develop Solution Experiences, industry-focused offerings that deliver specific value to companies and users in a particular industry. We serve eleven industries structured into three sectors:
Our product lines financial reporting include: 1) Industrial Innovation software revenue, comprised of our CATIA, ENOVIA, SIMULIA, DELMIA, GEOVIA, NETVIBES, and 3DEXCITE brands; 2) Life Sciences software revenue, comprised of our MEDIDATA and BIOVIA brands; and 3) Mainstream Innovation software revenue, comprised of CENTRIC PLM and 3DVIA brands as well as our 3DEXPERIENCE WORKS family which includes our SOLIDWORKS brand.
To measure the progressive penetration of 3DEXPERIENCE software, we use the following ratios: a) for Licenses revenue, we calculate the percentage contribution by comparing total 3DEXPERIENCE Licenses revenue to Licenses revenue for all product lines except SOLIDWORKS and acquisitions ("related Licenses revenue"); and, b) for software revenue, the Group calculates the percentage contribution by comparing total 3DEXPERIENCE software revenue to software revenue for all product lines except SOLIDWORKS and acquisitions ("related software revenue").
Non-IFRS key figures exclude the effects of adjusting the carrying value of acquired companies' contract liabilities (deferred revenue), share-based compensation expenses, including related social charges, amortization of acquired intangible assets and of tangible assets revaluation, lease incentives of acquired companies, other operating income and expense, net, including the acquisition, integration and restructuring expenses, and impairment of goodwill and acquired intangible assets, certain one-time items included in financial income (loss), net, certain one-time tax effects and the income tax effects of these non-IFRS adjustments.
Comparable IFRS financial information and a reconciliation of the IFRS and non-IFRS measures are set forth in the separate tables within this attachment.
| Non-IFRS reported | ||||||||
|---|---|---|---|---|---|---|---|---|
| In millions of Euros, except per share data, | Three months ended | Nine months ended | ||||||
| percentages, headcount and exchange rates | September 30, 2021 |
September 30, 2020 |
Change | Change in constant currencies |
September 30, 2021 |
September 30, 2020 |
Change | Change in constant currencies |
| Total Revenue | € 1,158.8 | € 1,030.2 | 12% | 12% | € 3,493.9 | € 3,245.2 | 8% | 11% |
| Revenue breakdown by activity | ||||||||
| Software revenue | 1,044.7 | 934.9 | 12% | 11% | 3,164.4 | 2,918.3 | 8% | 12% |
| Of which licenses and other software revenue | 208.3 | 167.0 | 25% | 24% | 635.2 | 508.5 | 25% | 29% |
| Of which subscription and support revenue | 836.4 | 767.9 | 9% | 8% | 2,529.2 | 2,409.8 | 5% | 9% |
| Services revenue | 114.1 | 95.4 | 20% | 19% | 329.5 | 326.8 | 1% | 4% |
| Software revenue breakdown by product line | ||||||||
| Industrial Innovation (1) | 555.3 | 513.9 | 8% | 8% | 1,735.6 | 1,664.7 | 4% | 7% |
| Life Sciences (2) | 226.5 | 190.1 | 19% | 19% | 654.7 | 578.9 | 13% | 19% |
| Mainstream Innovation | 262.9 | 230.8 | 14% | 13% | 774.1 | 674.8 | 15% | 20% |
| Revenue breakdown by geography | ||||||||
| Americas | 448.5 | 394.4 | 14% | 14% | 1,361.2 | 1,262.1 | 8% | 14% |
| Europe | 420.5 | 380.4 | 11% | 9% | 1,277.1 | 1,179.8 | 8% | 9% |
| Asia | 289.8 | 255.4 | 13% | 14% | 855.5 | 803.3 | 7% | 10% |
| Operating income | € 392.1 | € 290.9 | 35% | € 1,163.3 | € 911.2 | 28% | ||
| Operating margin | 33.8% | 28.2% | 33.3% | 28.1% | ||||
| Net income attributable to shareholders | € 296.5 | € 210.3 | 41% | € 885.1 | € 671.7 | 32% | ||
| Diluted earnings per share (3) | € 0.22 | € 0.16 | 40% | 40% | € 0.67 | € 0.51 | 31% | 36% |
| Closing headcount | 21,991 | 21,557 | 2% | 21,991 | 21,557 | 2% | ||
| Average Rate USD per Euro | 1.18 | 1.17 | 1% | 1.20 | 1.13 | 6% | ||
| Average Rate JPY per Euro | 129.76 | 124.05 | 5% | 129.83 | 120.91 | 7% |
(1) Excluding ENOVIA Life Sciences Compliance and Quality Management
(2) Including ENOVIA Life Sciences Compliance and Quality Management
(3) 2020 figures have been restated and 2021 presented in order to reflect the five-for-one stock split on Dassault Systèmes' share effected on July 7, 2021
(unaudited; in millions of Euros)
| In millions of Euros | Non-IFRS reported | o/w growth at | o/w change of | o/w FX impact on | ||
|---|---|---|---|---|---|---|
| September 30, | September 30, | constant rate and | scope impact at | previous year | ||
| 2021 | 2020 | Change | scope | current year rate | figures | |
| Revenue QTD | 1,158.8 | 1,030.2 | 128.6 | 123.3 | 0.5 | 4.7 |
| Revenue YTD | 3,493.9 | 3,245.2 | 248.7 | 351.8 | 2.4 | (105.6) |
(unaudited; in millions of Euros, except per share data and percentages)
| IFRS reported | ||||||
|---|---|---|---|---|---|---|
| In millions of Euros, except per share data and percentages | Three months ended | Nine months ended | ||||
| September 30, | September 30, | September 30, | September 30, | |||
| 2021 | 2020 | 2021 | 2020 | |||
| Licenses and other software revenue | 208.3 | 167.0 | 635.2 | 508.5 | ||
| Subscription and Support revenue | 836.3 | 767.3 | 2,527.9 | 2,398.8 | ||
| Software revenue | 1,044.6 | 934.3 | 3,163.1 | 2,907.3 | ||
| Services revenue | 114.1 | 95.3 | 329.2 | 325.7 | ||
| Total Revenue | € 1,158.7 | € 1,029.6 | € 3,492.4 | € 3,233.0 | ||
| Cost of software revenue (1) | (100.1) | (96.3) | (297.8) | (249.1) | ||
| Cost of services revenue | (92.2) | (88.7) | (285.6) | (316.6) | ||
| Research and development expenses | (233.8) | (230.1) | (700.2) | (703.7) | ||
| Marketing and sales expenses | (303.5) | (294.1) | (922.9) | (941.4) | ||
| General and administrative expenses | (93.7) | (85.9) | (283.5) | (284.3) | ||
| Amortization of acquired intangible assets and of tangible assets revaluation | (95.2) | (92.8) | (273.9) | (302.7) | ||
| Other operating income and expense, net | (3.2) | (17.0) | (27.3) | (48.9) | ||
| Total Operating Expenses | (921.7) | (904.9) | (2,791.2) | (2,846.6) | ||
| Operating Income | € 237.0 | € 124.7 | € 701.1 | € 386.4 | ||
| Financial loss, net | (4.7) | (5.9) | (12.6) | (18.9) | ||
| Income before income taxes | € 232.3 | € 118.8 | € 688.5 | € 367.4 | ||
| Income tax expense | (52.3) | (27.7) | (151.9) | (87.1) | ||
| Net Income | € 180.1 | € 91.0 | € 536.6 | € 280.3 | ||
| Non-controlling interest | (0.5) | 0.9 | 0.0 | 6.9 | ||
| Net Income attributable to equity holders of the parent | € 179.5 | € 91.9 | € 536.6 | € 287.3 | ||
| Basic earnings per share (2) | 0.14 | 0.07 | 0.41 | 0.22 | ||
| Diluted earnings per share (2) | € 0.14 | € 0.07 | € 0.41 | € 0.22 | ||
| Basic weighted average shares outstanding (in millions) | 1,313.4 | 1,305.5 | 1,309.7 | 1,301.4 | ||
| Diluted weighted average shares outstanding (in millions) | 1,325.4 | 1,315.9 | 1,324.3 | 1,314.9 |
(1) Excluding amortization of acquired intangible assets and of tangible assets revaluation
(2) 2020 figures have been restated in order to reflect the five-for-one share split on Dassault Systèmes' share effected on July 7, 2021
| Three months ended September 30, 2021 | Nine months ended September 30, 2021 | ||||
|---|---|---|---|---|---|
| IFRS reported | Change (5) | Change in constant | Change (5) | Change in constant | |
| currencies | currencies | ||||
| Revenue | 13% | 12% | 8% | 12% | |
| Revenue by activity | |||||
| Software revenue | 12% | 11% | 9% | 12% | |
| Services revenue | 20% | 19% | 1% | 4% | |
| Software Revenue by product line | |||||
| Industrial Innovation (3) | 8% | 8% | 4% | 7% | |
| Life Sciences (4) | 19% | 20% | 15% | 21% | |
| Mainstream Innovation | 14% | 13% | 15% | 20% | |
| Revenue by geography | |||||
| Americas | 14% | 14% | 9% | 15% | |
| Europe | 11% | 9% | 8% | 9% | |
| Asia | 13% | 14% | 7% | 10% |
(3) Excluding ENOVIA Life Sciences Compliance and Quality Management
(4) Including ENOVIA Life Sciences Compliance and Quality Management
(5) Variation compared to the same period in the prior year
(unaudited; in millions of Euros)
| IFRS reported | |||||
|---|---|---|---|---|---|
| In millions of Euros | September 30, | December 31, | |||
| 2021 | 2020 | ||||
| ASSETS | |||||
| Cash and cash equivalents | 2,670.4 | 2,148.9 | |||
| Trade accounts receivable, net | 981.9 | 1,229.1 | |||
| Contract assets | 15.0 | 27.0 | |||
| Other current assets | 333.3 | 355.4 | |||
| Total current assets | 4,000.6 | 3,760.3 | |||
| Property and equipment, net | 823.5 | 861.1 | |||
| Goodwill and Intangible assets, net | 8,084.6 | 7,937.2 | |||
| Other non-current assets | 461.4 | 405.6 | |||
| Total non-current assets | 9,369.5 | 9,203.9 | |||
| Total Assets | € 13,370.1 | € 12,964.2 | |||
| LIABILITIES AND EQUITY | |||||
| Trade accounts payable | 141.6 | 171.7 | |||
| Contract liabilities | 1,155.2 | 1,169.1 | |||
| Borrowings, current | 902.4 | 16.0 | |||
| Other current liabilities | 681.1 | 730.1 | |||
| Total current liabilities | 2,880.4 | 2,086.9 | |||
| Borrowings, non-current | 2,962.7 | 4,174.3 | |||
| Other non-current liabilities | 1,564.3 | 1,596.9 | |||
| Total non-current liabilities | 4,527.0 | 5,771.2 | |||
| Non-controlling interests | 8.4 | 44.8 | |||
| Parent shareholders' equity | 5,954.2 | 5,061.3 | |||
| Total Liabilities and equity | € 13,370.1 | € 12,964.2 |
| (unaudited; in millions of Euros) | |||||||
|---|---|---|---|---|---|---|---|
| IFRS reported | |||||||
| In millions of Euros | Three months ended | Nine months ended | |||||
| September 30, | September 30, | Change | September 30, | September 30, | Change | ||
| 2021 | 2020 | 2021 | 2020 | ||||
| Net income attributable to equity holders of the parent | 179.5 | 91.9 | 87.6 | 536.6 | 287.3 | 249.3 | |
| Non-controlling interest | 0.5 | (0.9) | 1.4 | - | (6.9) | 6.9 | |
| Net income | 180.1 | 91.0 | 89.1 | 536.6 | 280.3 | 256.3 | |
| Depreciation of property and equipment | 43.4 | 43.8 | (0.4) | 130.4 | 135.5 | (5.1) | |
| Amortization of intangible assets | 96.5 | 96.1 | 0.4 | 283.1 | 312.3 | (29.2) | |
| Adjustments for other non-cash items | 25.2 | 33.5 | (8.3) | 104.4 | 103.4 | 1.0 | |
| Changes in working capital | (129.0) | (116.1) | (12.9) | 194.9 | 171.8 | 23.1 | |
| Net Cash Provided by (Used in) Operating Activities | € 216.1 | € 148.3 | € 67.8 | € 1,249.4 | € 1,003.3 | € 246.1 | |
| Additions to property, equipment and intangibles | (17.0) | (17.3) | 0.3 | (73.7) | (104.7) | 31.0 | |
| Purchases of short-term investments | (0.2) | - | (0.2) | (0.2) | - | (0.2) | |
| Payment for acquisition of businesses, net of cash acquired | (7.4) | (0.6) | (6.8) | (7.4) | (20.0) | 12.6 | |
| Other | (2.3) | 0.1 | (2.4) | (11.5) | 2.5 | (14.0) | |
| Net Cash Provided by (Used in) Investing Activities | € (26.9) | € (17.8) | € (9.1) | € (92.9) | € (122.2) | € 29.3 | |
| Proceeds from exercise of stock options | 47.9 | 28.7 | 19.2 | 122.8 | 76.0 | 46.8 | |
| Cash dividends paid | - | - | - | (147.1) | (182.5) | 35.4 | |
| Repurchase and sale of treasury stock | (161.9) | 1.0 | (162.9) | (256.3) | (103.7) | (152.6) | |
| Acquisition of non-controlling interests | (0.1) | - | (0.1) | (0.1) | - | (0.1) | |
| Proceeds from borrowings | 1.3 | 10.4 | (9.1) | 1.3 | 12.2 | (10.9) | |
| Repayment of borrowings | (329.3) | (0.1) | (329.2) | (340.5) | (0.1) | (340.4) | |
| Repayment of lease liabilities | (24.0) | (22.0) | (2.0) | (73.2) | (69.4) | (3.8) | |
| Net Cash Provided by (Used in) Financing Activities | € (466.1) | € 18.0 | € (484.1) | € (693.1) | € (267.4) | € (425.7) | |
| Effect of exchange rate changes on cash and cash equivalents | 28.3 | (42.0) | 70.3 | 58.2 | (52.5) | 110.7 | |
| Increase (decrease) in cash and cash equivalents | € (248.6) | € 106.4 | € (355.0) | € 521.5 | € 561.2 | € (39.7) | |
| Cash and cash equivalents at beginning of period | € 2,919.0 | € 2,399.7 | € 2,148.9 | € 1,944.9 | |||
| Cash and cash equivalents at end of period | € 2,670.4 | € 2,506.1 | € 2,670.4 | € 2,506.1 |
Readers are cautioned that the supplemental non-IFRS information presented in this press release is subject to inherent limitations. It is not based on any comprehensive set of accounting rules or principles and should not be considered as a substitute for IFRS measurements. Also, the Group's supplemental non-IFRS financial information may not be comparable to similarly titled "non-IFRS" measures used by other companies. Further specific limitations for individual non-IFRS measures, and the reasons for presenting non-IFRS financial information, are set forth in the Group's Document d'Enregistrement Universel for the year ended December 31, 2020 filed with the AMF on March 19, 2021. To compensate for these limitations, the supplemental non-IFRS financial information should be read not in isolation, but only in conjunction with the Group's consolidated financial statements prepared in accordance with IFRS.
| In millions of Euros, except per share data and | Three months ended September 30, | Change | ||||||
|---|---|---|---|---|---|---|---|---|
| percentages | 2021 IFRS |
Adjustment(1) | 2021 Non-IFRS |
2020 IFRS |
Adjustment(1) | 2020 Non-IFRS |
IFRS | Non IFRS(4) |
| Total Revenue | € 1,158.7 | € 0.1 | € 1,158.8 | € 1,029.6 | € 0.6 | € 1,030.2 | 13% | 12% |
| Revenue breakdown by activity | ||||||||
| Software revenue | 1,044.6 | 0.1 | 1,044.7 | 934.3 | 0.5 | 934.9 | 12% | 12% |
| Licenses and other software revenue | 208.3 | - | 208.3 | 167.0 | - | 167.0 | 25% | 25% |
| Subscription and Support revenue | 836.3 | 0.1 | 836.4 | 767.3 | 0.5 | 767.9 | 9% | 9% |
| Recurring portion of Software revenue | 80% | 80% | 82% | 82% | ||||
| Services revenue | 114.1 | - | 114.1 | 95.3 | 0.1 | 95.4 | 20% | 20% |
| Software Revenue breakdown by product line | ||||||||
| Industrial Innovation (2) | 555.3 | - | 555.3 | 513.9 | - | 513.9 | 8% | 8% |
| Life Sciences (3) | 226.5 | - | 226.5 | 189.8 | 0.4 | 190.1 | 19% | 19% |
| Mainstream Innovation | 262.9 | 0.1 | 262.9 | 230.7 | 0.1 | 230.8 | 14% | 14% |
| Revenue breakdown by geography | ||||||||
| Americas | 448.5 | 0.1 | 448.5 | 393.9 | 0.5 | 394.4 | 14% | 14% |
| Europe | 420.4 | 0.0 | 420.5 | 380.3 | 0.1 | 380.4 | 11% | 11% |
| Asia | 289.8 | - | 289.8 | 255.4 | - | 255.4 | 13% | 13% |
| Total Operating Expenses | € (921.7) | € 155.0 | € (766.7) | € (904.9) | € 165.6 | € (739.3) | 2% | 4% |
| Share-based compensation expense and related social | ||||||||
| charges | (56.0) | 56.0 | - | (55.1) | 55.1 | - | ||
| Amortization of acquired intangible assets and of | ||||||||
| tangible assets revaluation | (95.2) | 95.2 | - | (92.8) | 92.8 | - | ||
| Lease incentives of acquired companies | (0.7) | 0.7 | - | (0.7) | 0.7 | - | ||
| Other operating income and expense, net | (3.2) | 3.2 | - | (17.0) | 17.0 | - | ||
| Operating Income | € 237.0 | € 155.1 | € 392.1 | € 124.7 | € 166.2 | € 290.9 | 90% | 35% |
| Operating Margin | 20.5% | 33.8% | 12.1% | 28.2% | ||||
| Financial loss, net | (4.7) | 0.4 | (4.2) | (5.9) | 0.2 | (5.7) | (22)% | (26)% |
| Income tax expense | (52.3) | (37.7) | (89.9) | (27.7) | (46.6) | (74.3) | 88% | 21% |
| Non-controlling interest | (0.5) | (0.9) | (1.5) | 0.9 | (1.4) | (0.5) | (162)% | 182% |
| Net Income attributable to shareholders | € 179.5 | € 116.9 | € 296.5 | € 91.9 | € 118.4 | € 210.3 | 95% | 41% |
| Diluted Earnings Per Share (5) | € 0.14 | € 0.09 | € 0.22 | € 0.07 | € 0.09 | € 0.16 | 94% | 40% |
(1) In the reconciliation schedule above, (i) all adjustments to IFRS revenue data reflect the exclusion of the effect of adjusting the carrying value of acquired companies' contract liabilities (deferred revenue); (ii) adjustments to IFRS operating expense data reflect the exclusion of the amortization of acquired intangible assets and of tangible assets revaluation, share-based compensation expense, including related social charges, lease incentives of acquired companies, as detailed below, and other operating income and expense, net including acquisition, integration and restructuring expenses, and impairment of goodwill and acquired intangible assets (iii) adjustments to IFRS financial loss, net reflect the exclusion of certain one-time items included in financial loss, net, and (iv) all adjustments to IFRS income data reflect the combined effect of these adjustments, plus with respect to net income and diluted earnings per share, certain one-time tax effects and the income tax effect of the non-IFRS adjustments.
| Three months ended September 30, | Change | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| In millions of Euros, except percentages |
2021 IFRS |
Share-based compensation expense and related social charges |
Lease incentives of acquired companies |
2021 Non-IFRS |
2020 IFRS |
Share-based compensation expense and related social charges |
Lease incentives of acquired companies |
2020 Non-IFRS |
IFRS | Non IFRS |
| Cost of revenue | (192.3) | 3.2 | 0.2 | (188.9) | (185.0) | 3.6 | 0.2 | (181.2) | 4% | 4% |
| Research and development expenses |
(233.8) | 21.2 | 0.3 | (212.3) | (230.1) | 19.9 | 0.3 | (209.9) | 2% | 1% |
| Marketing and sales expenses | (303.5) | 17.1 | 0.1 | (286.3) | (294.1) | 16.4 | 0.1 | (277.6) | 3% | 3% |
| General and administrative expenses |
(93.7) | 14.5 | 0.1 | (79.1) | (85.9) | 15.2 | 0.1 | (70.7) | 9% | 12% |
| Total | € 56.0 | € 0.7 | € 55.1 | € 0.7 |
(2) Excluding ENOVIA Life Sciences Compliance and Quality Management.
(3) Including ENOVIA Life Sciences Compliance and Quality Management.
(4) The non-IFRS percentage increase (decrease) compares non-IFRS measures for the two different periods. In the event there is non-IFRS adjustment to the relevant measure for only one of the periods under comparison, the non-IFRS increase (decrease) compares the non-IFRS measure to the relevant IFRS measure. (5) Based on a weighted average 1,325.4 million diluted shares for Q3 2021 and 1,315.9 million diluted shares for Q3 2020. 2020 figures have been restated in order to reflect the five-for-one share split on Dassault Systèmes' share effected on July 7, 2021.
Readers are cautioned that the supplemental non-IFRS information presented in this press release is subject to inherent limitations. It is not based on any comprehensive set of accounting rules or principles and should not be considered as a substitute for IFRS measurements. Also, the Group's supplemental non-IFRS financial information may not be comparable to similarly titled "non-IFRS" measures used by other companies. Further specific limitations for individual non-IFRS measures, and the reasons for presenting non-IFRS financial information, are set forth in the Group's Document d'Enregistrement Universel for the year ended December 31, 2020 filed with the AMF on March 19, 2021. To compensate for these limitations, the supplemental non-IFRS financial information should be read not in isolation, but only in conjunction with the Group's consolidated financial statements prepared in accordance with IFRS.
| Nine months ended September 30, | Change | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| In millions of Euros, except per share data and percentages |
2021 IFRS |
Adjustment(1) | 2021 Non-IFRS |
2020 IFRS |
Adjustment(1) | 2020 Non-IFRS |
IFRS | Non IFRS(4) |
|
| Total Revenue | € 3,492.4 | € 1.5 | € 3,493.9 | € 3,233.0 | € 12.2 | € 3,245.2 | 8% | 8% | |
| Revenue breakdown by activity | |||||||||
| Software revenue | 3,163.1 | 1.3 | 3,164.4 | 2,907.3 | 11.0 | 2,918.3 | 9% | 8% | |
| Licenses and other software revenue | 635.2 | - | 635.2 | 508.5 | - | 508.5 | 25% | 25% | |
| Subscription and Support revenue | 2,527.9 | 1.3 | 2,529.2 | 2,398.8 | 11.0 | 2,409.8 | 5% | 5% | |
| Recurring portion of Software revenue | 80% | 80% | 83% | 83% | |||||
| Services revenue | 329.2 | 0.2 | 329.5 | 325.7 | 1.2 | 326.8 | 1% | 1% | |
| Software Revenue breakdown by product line | |||||||||
| Industrial Innovation (2) | 1,735.6 | - | 1,735.6 | 1,663.9 | 0.8 | 1,664.7 | 4% | 4% | |
| Life Sciences (3) | 653.7 | 1.0 | 654.7 | 569.2 | 9.7 | 578.9 | 15% | 13% | |
| Mainstream Innovation | 773.8 | 0.3 | 774.1 | 674.2 | 0.5 | 674.8 | 15% | 15% | |
| Revenue breakdown by geography | |||||||||
| Americas | 1,359.9 | 1.3 | 1,361.2 | 1,250.7 | 11.5 | 1,262.1 | 9% | 8% | |
| Europe | 1,277.0 | 0.1 | 1,277.1 | 1,179.4 | 0.4 | 1,179.8 | 8% | 8% | |
| Asia | 855.5 | - | 855.5 | 802.9 | 0.4 | 803.3 | 7% | 7% | |
| Total Operating Expenses | € (2,791.2) | € 460.7 | € (2,330.5) | € (2,846.6) | € 512.7 | € (2,333.9) | (2)% | (0)% | |
| Share-based compensation expense and related social | 157.4 | - | (158.9) | 158.9 | - | ||||
| charges | (157.4) | ||||||||
| Amortization of acquired intangible assets and of | (273.9) | 273.9 | - | (302.7) | 302.7 | - | |||
| tangible assets revaluation | |||||||||
| Lease incentives of acquired companies | (2.1) | 2.1 | - | (2.2) | 2.2 | - | |||
| Other operating income and expense, net | (27.3) | 27.3 | - | (48.9) | 48.9 | - | |||
| Operating Income | € 701.1 | € 462.2 | € 1,163.3 | € 386.4 | € 524.9 | € 911.2 | 81% | 28% | |
| Operating Margin | 20.1% | 33.3% | 12.0% | 28.1% | |||||
| Financial loss, net | (12.6) | 1.2 | (11.4) | (18.9) | 0.7 | (18.2) | (33)% | (37)% | |
| Income tax expense | (151.9) | (111.3) | (263.2) | (87.1) | (137.3) | (224.4) | 74% | 17% | |
| Non-controlling interest | 0.0 | (3.6) | (3.6) | 6.9 | (3.9) | 3.0 | (100)% | (220)% | |
| Net Income attributable to shareholders | € 536.6 | € 348.5 | € 885.1 | € 287.3 | € 384.4 | € 671.7 | 87% | 32% | |
| Diluted Earnings Per Share (5) | € 0.41 | € 0.26 | € 0.67 | € 0.22 | € 0.29 | € 0.51 | 85% | 31% |
(1) In the reconciliation schedule above, (i) all adjustments to IFRS revenue data reflect the exclusion of the effect of adjusting the carrying value of acquired companies' contract liabilities (deferred revenue); (ii) adjustments to IFRS operating expense data reflect the exclusion of the amortization of acquired intangible assets and of tangible assets revaluation, share-based compensation expense, including related social charges, lease incentives of acquired companies, as detailed below, and other operating income and expense, net including acquisition, integration and restructuring expenses, and impairment of goodwill and acquired intangible assets (iii) adjustments to IFRS financial loss, net reflect the exclusion of certain one-time items included in financial loss, net, and (iv) all adjustments to IFRS income data reflect the combined effect of these adjustments, plus with respect to net income and diluted earnings per share, certain one-time tax effects and the income tax effect of the non-IFRS adjustments.
| Nine months ended September 30, | Change | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| In millions of Euros, except percentages |
2021 IFRS |
Share-based compensation expense and related social charges |
Lease incentives of acquired companies |
2021 Non-IFRS |
2020 IFRS |
Share-based compensation expense and related social charges |
Lease incentives of acquired companies |
2020 Non-IFRS |
IFRS | Non IFRS |
| Cost of revenue | (583.4) | 10.1 | 0.6 | (572.7) | (565.7) | 9.6 | 0.6 | (555.4) | 3% | 3% |
| Research and development expenses |
(700.2) | 55.3 | 0.9 | (644.0) | (703.7) | 56.6 | 1.0 | (646.0) | (0)% | (0)% |
| Marketing and sales expenses | (922.9) | 45.0 | 0.3 | (877.6) | (941.4) | 46.6 | 0.3 | (894.4) | (2)% | (2)% |
| General and administrative expenses |
(283.5) | 47.0 | 0.2 | (236.3) | (284.3) | 46.0 | 0.3 | (238.0) | (0)% | (1)% |
| Total | € 157.4 | € 2.1 | € 158.9 | € 2.2 |
(2) Excluding ENOVIA Life Sciences Compliance and Quality Management.
(3) Including ENOVIA Life Sciences Compliance and Quality Management.
(4) The non-IFRS percentage increase (decrease) compares non-IFRS measures for the two different periods. In the event there is non-IFRS adjustment to the relevant measure for only one of the periods under comparison, the non-IFRS increase (decrease) compares the non-IFRS measure to the relevant IFRS measure. (5) Based on a weighted average 1,324.3 million diluted shares for YTD 2021 and 1,314.9 million diluted shares for YTD 2020. 2020 figures have been restated in order
to reflect the five-for-one share split on Dassault Systèmes' share effected on July 7, 2021.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.